Need Help? Call 1­-866-­796-­7386
« back to stock screener

  AGLE stock: Aeglea Bio Therapeutics Inc

Current Rating
Strong Sell

Previous Rating:

Strong Sell
Our Stock Ratings
double the S&P500!
Learn more.
Company Statistics
Price
$5.52
Market Cap
71.7M
Sector
Health Care
Div. Growth
-
P/E
-
P/B
1.04
P/S
14.26
Dividend %
-
P/CF
3.0
P/FCF
-
Op. Cash Flow
-15.3K
FCF
-1.2
Op. Margin
-409.30%
Net Margin
-406.80%
ROE
-86.60%
ROI
51.00%
ROA
-36.10%
EPS Growth
-78.70%
Current Ratio
15.3
Debt/Equity
-
Company Price P/E Div. Yield Market Cap ($Mil) Rating
Wound Management Technologies (WNDM) $0.05 - - 5.4M Strong Buy
Spine Injury Solutions Inc (SPIN) $0.22 - - 5M Strong Buy
Daxor Corporation (DXR) $8.70 - 0.30% 34.4M Strong Buy
Fibrocell Science Inc (FCSC) $0.78 - - 42.2M Strong Buy
American Renal Associates Hold (ARA) $23.80 - - 676.6M Strong Buy
Find great stocks now!
Avoid risky stocks
Enter your favorite tickers and click “Get Ratings”

Disclaimer

Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.

All analysis relies on publicly available financial information. Learn More